(2022). Effect of competing mortality risks on predictive performance of the QFracture risk prediction tool for major osteoporotic fracture and hip fracture: external validation cohort study in a UK primary care population. Bmj Med, 1, e000316. http://doi.org/10.1136/bmjmed-2022-000316.
(2023). Derivation and validation of the CFracture competing risk fracture prediction tool compared with QFracture in older people and people with comorbidity: a population cohort study. Lancet Healthy Longev, 4, e43-e53. http://doi.org/10.1016/s2666-7568(22)00290-2.
(2022). Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study. Bmc Med, 20, 152. http://doi.org/10.1186/s12916-022-02349-6.